[dogma1138]

That’s true even if the mutation is the same it’s hard to actually fix it, while reactivating or over-expressing a gene that already exists and works is much easier.

For this specific case it’s also better because lesser coverage might still produce sufficient results since fetal hemoglobin out competes adult hemoglobin.

I think in general CRISPR would be patch over rather than a point fix.